• Memorial Hermann (Texas Medical Center, Southwest, Sugar Land, Memorial City, Northwest, and Katy

• Methodist Sugar Land

• Select Specialty 

• Cornerstone

  Julio Peguero, Bert O'Neil, Davendra Sohal et al. Genomic mutation profiling (GMP) and clinical outcome in patients (pts) treated with ribociclib (CDK4/6 inhibitor) in the Signature Program. (Proceedings ASCO 2016, Abst # 2528)

 

Hope S. Rugo, Lasika Seneviratne, J. Thaddeus Beck, John A. Glaspy, Julio A. Peguero S-N, Timothy J. Pluard, Navneet Dhillon et al. Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal women with hormone receptor-positive (HR+) metastatic breast cancer using a dexamethasone-based mouthwash (MW): results of the SWISH trial (Proceedings ASCO 2016, Abst # 525  ​

 

Julio Peguero, James A. Knost, Matthew Taylor, Fadi Braiteh, Paul Eder, Howard Safran, Bert O’Neil, Ajjai Alva, Lincoln Nadauld, Prashant Joshi, Rajinder Sidhu, Joy Ero, Eric Slosberg, Claudia Lebedinsky, Barinder Kang, Sudha Parasuraman, Sarina A. Piha-Paul Successful implementation of a novel trial model: The Signature program, ASCO J Clin Oncol 33, 2015 (suppl; abstr 106) ASCO (Oral Presentation)

 

Barinder K, Slosberg E, Piha Paul S, Braiteh F, Peguero J, Spitz D*, Knost J*, Berry D, Salvado A, Stein S, Lebedinsky C., Metastatic Breast Cancers By FoundationOne® Allows A Broad Genomic Understanding For Potential Clinical Implications The Signature Program, a Series of Tissue-Agnostic, Mutation-Specific Signal-Finding Trials May Clinic Proceedings 2014 ASCO (Poster)

 

Frank Giles, MD, MB, FRCPI, FRCPath1, Sarina A. Piha-Paul, MD2*, Alexander I. Spira, PhD, MD, FACP3, Fadi Braiteh, MD, CPI4*, Julio Antonio Peguero, MD5*, Daniel L. Spitz, MD, FACP6*, James A. Knost, MD7*, Lee Schwartzberg, MD, FACP8, Steven Stein, MD9, August J. Salvado, MD10, Claudia Lebedinsky, MD10*, Barinder Kang, PhD10* and Eric Slosberg, PhD10*The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients December 2014 ASH (Poster)

 

Norma A. Palma, Siraj Ali, Garrett Frampton, Kai Wang, 2Hannah Gilmore, Julio Peguero, Lyndsay Harris, Massimo Cristofanilli, Juliann Chmielecki, Jeffrey S. Ross, 1Deborah Morosini,1Vincent A. Miller, Phil Stephens, Gary Palmer, Joyce, SABCS 2014, Profiling Of ESR1-Mutated Abstract PD6-5: Profiling of ESR1-mutated metastatic breast cancers by FoundationOne® allows a broad genomic understanding for potential clinical implications December 2014 SABCS (Poster)

 

Peguero JA, Kemp B, Camacho LH and Campos LT, Role of chemokines in tumor to tumor metastasis. Poster presented at: Texas Society of Medical Oncology, Houston Texas October 2007; Houston, TX. (Poster)
 

Peguero JA and Gasic S;. (2009, May). Idiopathic Aplastic Anemia treated with imunosupressants and Teriparatide; Poster presented at: Central Texas Research Meeting; Austin, TX. (Poster)
 

Pilar Acosta M.D, Julio Peguero M.D, Maurice Willis M.D, Spontaneous tumor lysis syndrome in rectal adenocarcinoma, Poster presentation UTMB, Internal Medicine Poster Presentations (2012,May) (Poster)

 

Kershaw Patel, Peguero Julio, Goodgame Richard, Alperin Jack; Bloody Bowels: The Source Runs Deep, First place in Texas ACP, Medical Student Abstract Competition (12/05/12) (Poster)

 

Peguero JA and Gasic S;. (2009, May). Idiopathic Aplastic Anemia treated with imunosupressants and Teriparatide; Poster presented at: Central Texas Research Meeting; Austin, TX. (Poster)  

1. Signature Program: Have Basket Trials Come of Age? Eric D. Slosberg, Barinder Kang, Julio Peguero, Matthew Taylor, Todd M. Bauer, Don A. Berry, Fadi S. Braiteh, Alexander Spira, Funda Meric-Bernstam, Steven Stein, Sarina A. Piha-Paul, August Salvado; (Sent to JCO;2016)

2. Julio Peguero, James A. Knost, Matthew Taylor, Fadi Braiteh, Paul Eder, Howard Safran, Bert O’Neil, Ajjai Alva, Lincoln Nadauld, Prashant Joshi, Rajinder Sidhu, Joy Ero, Eric Slosberg, Claudia Lebedinsky, Barinder Kang, Sudha Parasuraman, Sarina A. Piha-Paul Successful implementation of a novel trial model: The Signature program, ASCO J Clin Oncol 33, 2015

3. Barinder K, Slosberg E, Piha Paul S, Braiteh F, Peguero J, Spitz D*, Knost J*, Berry D, Salvado A, Stein S, Lebedinsky C., Metastatic Breast Cancers By FoundationOne® Allows A Broad Genomic Understanding For Potential Clinical Implications The Signature Program, a Series of Tissue-Agnostic, Mutation-Specific Signal-Finding Trials, December 6, 2014; Blood: 124 (21)

4. Julio Peguero-S.N M.D., Anas Khanfar M.B.B.S., Siva Mannem M.D., Maurice Willis M and Avi Markowtiz M.D, Impending Carotid Blow Out Syndrome: Response To Multimodality Therapy In Giant Size Head And Neck Squamous Cell Carcinoma; JCO; March 31, 2014, doi:10.1200/JCO.2013.48.9641

5. Peguero JA, Camacho LH, Kemp B, Campos LT. Chemokine expression in tumor-to-tumor metastasis. Oncol Lett. 2010 May;1(3):449-52. PMCID 3436450

6. Breast Cancer. 2008 Dec; 16(2): 192-199Receptor Negative Peguero JA, Gonzalez-Angulo AM. Revista Med Triple